FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

It is estimated that one in five people in Northern Ireland are living with a chronic pain condition like arthritis, ...

Some forms of exercise training and pharmacological-based interventions may improve fibromyalgia-related sleep disturbances, though evidence is limited.

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...

Clifton was diagnosed with anxiety and depression as a teen. She used her mental diagnoses and her physical diagnosis; ...

Lady Gaga is on the mend following a lengthy and painful battle with fibromyalgia. “It’s very under control. It took over my life for a long time, but I’m 95 percent better,” Gaga, 38, told The Sunday ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according ...

Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

The FDA previously granted Fast Track designation to TNX-102 SL for the management of fibromyalgia in 2024, a designation intended to expedite FDA review of important new drugs to treat serious ...